{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:19:59Z","timestamp":1779272399960,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1045619"],"award-info":[{"award-number":["APP1045619"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP628699"],"award-info":[{"award-number":["APP628699"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government's Operational Infrastructure Support"},{"name":"Rebecca Cooper Medical Research Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.schres.2015.10.028","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:30:29Z","timestamp":1446683429000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-4473","authenticated-orcid":false,"given":"Brian","family":"Dean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Scarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2015.10.028_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cne.1186","article-title":"Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways","volume":"434","author":"Alcantara","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.10.028_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0925-4927(96)02947-2","article-title":"The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics","volume":"68","author":"Beckmann","year":"1997","journal-title":"Psychiatry Res."},{"issue":"23","key":"10.1016\/j.schres.2015.10.028_bb0015","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1523\/JNEUROSCI.18-23-10207.1998","article-title":"Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation","volume":"18","author":"Bernard","year":"1998","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2015.10.028_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2015.10.028_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.schres.2015.10.028_bb0030","first-page":"148","article-title":"Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders","volume":"30","author":"Conn","year":"2009","journal-title":"TIPS"},{"key":"10.1016\/j.schres.2015.10.028_bb0035","series-title":"Applied Regression Including Computing and Graphics","author":"Cook","year":"1999"},{"issue":"19","key":"10.1016\/j.schres.2015.10.028_bb0040","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0024-3205(99)00114-9","article-title":"The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia","volume":"64","author":"Crook","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.schres.2015.10.028_bb0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00031305.1990.10475751","article-title":"A suggestion for using powerful and informative tests of normality","volume":"44","author":"D'Agostino","year":"1990","journal-title":"Am. Stat."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0050","first-page":"54","article-title":"The density of muscarinic M1 receptors is decreased in the caudate\u2013putamen of subjects with schizophrenia","volume":"1","author":"Dean","year":"1996","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mp.4000684","article-title":"Muscarinic1 and 2 receptor mRNA in the human caudate\u2013putamen: no change in m1 mRNA in schizophrenia","volume":"5","author":"Dean","year":"2000","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.10.028_bb0060","first-page":"217","article-title":"Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia","volume":"40","author":"Dean","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2015.10.028_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.mp.4001199","article-title":"Decreased muscarinic(1) receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"7","author":"Dean","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2015.10.028_bb0070","series-title":"Using CNS Tissue in Psychiatric Research: A Practical Guide","first-page":"67","article-title":"The localisation and quantification of molecular changes in the human brain using in situ radioligand binding and autoradiography","author":"Dean","year":"1999"},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-1781(00)00104-9","article-title":"Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia","volume":"93","author":"Falke","year":"2000","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/nen.0b013e31802c3e7d","article-title":"Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe study","volume":"66","author":"Ferrer","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.schres.2015.10.028_bb0085","first-page":"1","article-title":"Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia","author":"Gibbons","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cyto.a.20031","article-title":"Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex","volume":"60","author":"Gylys","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.schres.2015.10.028_bb0095","series-title":"The Human Nervous System","first-page":"678","article-title":"The basal ganglia","author":"Haber","year":"2011"},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jnr.21491","article-title":"Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain","volume":"86","author":"Han","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.schres.2015.10.028_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/ajp.153.4.533","article-title":"Problem of diagnosis in postmortem brain studies of schizophrenia","volume":"153","author":"Hill","year":"1996","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.schres.2015.10.028_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pnpbp.2013.08.001","article-title":"The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders","volume":"47","author":"Jeon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2015.10.028_bb0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/syn.890020511","article-title":"Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia","volume":"2","author":"Joyce","year":"1988","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-328X(94)00219-5","article-title":"Tissue pH as an indicator of mRNA preservation in human post-mortem brain","volume":"28","author":"Kingsbury","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.58.2.165","article-title":"A separate disease within the syndrome of schizophrenia","volume":"58","author":"Kirkpatrick","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.06.012","article-title":"Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression","volume":"78","author":"Kristiansen","year":"2005","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ajmg.b.20020","article-title":"Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia","volume":"119","author":"Mancama","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2006.09.011","article-title":"Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder","volume":"1127","author":"McCullumsmith","year":"2007","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1037\/0021-843X.110.1.40","article-title":"Misunderstanding analysis of covariance","volume":"110","author":"Miller","year":"2001","journal-title":"J. Abnorm. Psychol."},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3565(25)20469-4","article-title":"Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors","volume":"259","author":"Miller","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9426","key":"10.1016\/j.schres.2015.10.028_bb0155","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-0270(02)00036-5","article-title":"High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding","volume":"116","author":"Pavey","year":"2002","journal-title":"J. Neurosci. Methods"},{"issue":"6","key":"10.1016\/j.schres.2015.10.028_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","article-title":"Acetylcholine in mind: a neurotransmitter correlate of consciousness?","volume":"22","author":"Perry","year":"1999","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2015.10.028_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.160.1.118","article-title":"In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia","volume":"160","author":"Raedler","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00048679809062709","article-title":"Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience","volume":"32","author":"Roberts","year":"1998","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2015.10.028_bb0185","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/npp.2009.41","article-title":"Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q\/11) coupling in a schizophrenia endophenotype","volume":"34","author":"Salah-Uddin","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2015.10.028_bb0190","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2008.05711.x","article-title":"Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?","volume":"107","author":"Scarr","year":"2008","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.schres.2015.10.028_bb0195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mp.2008.28","article-title":"Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia","volume":"14","author":"Scarr","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2015.10.028_bb0200","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/tp.2013.3","article-title":"Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA","volume":"3","author":"Scarr","year":"2013","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.schres.2015.10.028_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fncel.2013.00055","article-title":"Cholinergic connectivity: it's implications for psychiatric disorders","volume":"7","author":"Scarr","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2015.10.028_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-5618.2006.00300.x","article-title":"Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder","volume":"8","author":"Scarr","year":"2006","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.schres.2015.10.028_bb0215","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.schres.2015.10.028_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.025","article-title":"Human postmortem tissue: what quality markers matter?","volume":"1123","author":"Stan","year":"2006","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.schres.2015.10.028_bb0230","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.neuroscience.2006.03.011","article-title":"Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain","volume":"140","author":"Terry","year":"2006","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.schres.2015.10.028_bb0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"15","key":"10.1016\/j.schres.2015.10.028_bb0240","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1\u2013M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:11:44Z","timestamp":1748682704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415300293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0920996415300293"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.10.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}